Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DQPF85
|
|||
| Drug Name |
VIB1116
|
|||
| Synonyms |
HZN-1116
Click to Show/Hide
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Autoimmune disease [ICD-11: 4A40-4A45] | Phase 1 | [1] | |
| Company |
HORIZON
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04948099) A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of VIB1116 in Conventional Dendritic Cell (cDC) and Plasmacytoid Dendritic Cell (pDC)-Mediated Rheumatic Diseases. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.